{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T18:52:22Z","timestamp":1776106342564,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Resistance of\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      against common anti-malarial drugs emphasizes the need of alternative and more effective drugs. Synthetic derivatives of 1-(heteroaryl)-2-((5-nitroheteroaryl)methylene) hydrazine have showed in vitro anti-plasmodial activities. The present study aimed to evaluate the molecular binding and anti-plasmodial activity of synthetic compounds in vivo.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The molecular docking was used to study the binding of compounds to haem and\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      lactate dehydrogenase (PfLDH). Acute toxicity of the synthetic compounds was evaluated based on the modified up &amp; down method. The anti-plasmodial activity of the compounds was conducted by the two standard tests of Peters\u2019 and of Rane, using chloroquine-sensitive\n                      <jats:italic>Plasmodium berghei<\/jats:italic>\n                      in mice. Also, the toxicity to the internal organs of mice was evaluated on the seventh day after the treatment in addition to the histopathology of their liver. Compound\n                      <jats:bold>3<\/jats:bold>\n                      that showed high activity in the lowest dose was selected for further pharmacodynamic studies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      According to the docking studies, the active site of PfLDH had at least four common residues, including Ala98, Ile54, Gly29, and Tyr97 to bind the compounds with the affinity, ranging from \u2212\u20098.0 to \u2212\u20098.4\u00a0kcal\/mol. The binding mode of ligands to haem revealed an effective binding affinity, ranging from \u2212\u20095.1 to \u2212\u20095.5\u00a0kcal\/mol. Compound\n                      <jats:bold>2<\/jats:bold>\n                      showed the highest \u00a0% suppression of parasitaemia (99.09%) at the dose of 125\u00a0mg\/kg\/day in Peters\u2019 test. Compound\n                      <jats:bold>3<\/jats:bold>\n                      , with 79.42% suppression, was the best in Rane\u2019s test at the lowest dose (31\u00a0mg\/kg\/day). Compound\n                      <jats:bold>3<\/jats:bold>\n                      was confirmed by the pharmacodynamic study to have faster initial parasite elimination in the lowest concentration. The histopathology of the livers of mice did not reveal any focal necrosis of hepatocytes in the studied compounds.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The docking studies verified\u00a0\n                      <jats:italic>Pf<\/jats:italic>\n                      \u00a0LDH inhibition and the inhibitory effect on the haemozoin formation for the studied compounds. Accordingly, some compounds may provide new avenues for the development of anti-malarial drugs without liver toxicity, although further studies are required to optimize their anti-plasmodial activity.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-020-03269-7","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T07:02:59Z","timestamp":1593414179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["In silico and in vivo anti-malarial investigation on 1-(heteroaryl)-2-((5-nitroheteroaryl)methylene) hydrazine derivatives"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1221-4490","authenticated-orcid":false,"given":"Azar","family":"Tahghighi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed-Mahdi","family":"Mohamadi-Zarch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamzeh","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahya","family":"Marashiyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naseh","family":"Maleki-Ravasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Eslamifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,29]]},"reference":[{"key":"3269_CR1","unstructured":"WHO. World malaria report 2018. Geneva: World Health Organization; 2018. (https:\/\/www.who.int\/malaria\/publications\/world-malaria-report-2018\/en\/)."},{"key":"3269_CR2","unstructured":"WHO. A framework for malaria elimination. Geneva: World Health Organization; 2017. (https:\/\/www.who.int\/malaria\/publications\/atoz\/9789241511988\/en\/)."},{"key":"3269_CR3","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nm.4381","volume":"23","author":"B Blasco","year":"2017","unstructured":"Blasco B, Leroy D, Fidock DA. Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic. Nat Med. 2017;23:917\u201328.","journal-title":"Nat Med"},{"key":"3269_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"E Ashley","year":"2014","unstructured":"Ashley E, Dhorda M, Fairhurst R, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411\u201323.","journal-title":"N Engl J Med"},{"key":"3269_CR5","unstructured":"WHO.World Malaria Report 2015. Geneva: World Health Organization; 2016. int\/iris\/bitstream\/10665\/200018\/1\/9789241565158_eng. pdf? ua\u2009=\u20091. Accessed Jan 2016."},{"key":"3269_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/tropicalmed4010026","volume":"4","author":"C Nsanzabana","year":"2019","unstructured":"Nsanzabana C. Resistance to artemisinin combination therapies (ACTs): do not forget the partner drug! Trop Med Infect Dis. 2019;4:26.","journal-title":"Trop Med Infect Dis."},{"key":"3269_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7324\/JAPS.2016.60324","volume":"6","author":"D Bhattacharjee","year":"2016","unstructured":"Bhattacharjee D, Shivaprakash G. Drug resistance in malaria\u2014in a nutshell. J Appl Pharm Sci. 2016;6:137\u201343.","journal-title":"J Appl Pharm Sci."},{"key":"3269_CR8","first-page":"202","volume":"21","author":"A Tahghighi","year":"2018","unstructured":"Tahghighi A, Karimi S, Parhizgar AR, Zakeri S. Synthesis and anti-plasmodial activity of novel phenanthroline derivatives: an in vivo study. Iran J Basic Med Sci. 2018;21:202\u201311.","journal-title":"Iran J Basic Med Sci."},{"key":"3269_CR9","doi-asserted-by":"crossref","unstructured":"Christensen SB. Drugs and drug leads based on natural products for treatment and prophylaxis of malaria. In: Evidence-Based Validation of Herbal Medicine. PK Mukherjee, Ed. Elsevier; 2015:307-19.","DOI":"10.1016\/B978-0-12-800874-4.00014-3"},{"key":"3269_CR10","first-page":"270","volume":"20","author":"H Afrouzan","year":"2017","unstructured":"Afrouzan H, Zakeri S, Mehrizi AA, Molasalehi S, Tahghighi A, Shokrgozar MA, et al. Anti-plasmodial assessment of four different Iranian propolis extracts. Arch Iran Med. 2017;20:270\u201381.","journal-title":"Arch Iran Med."},{"key":"3269_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40794-016-0027-8","volume":"2","author":"B Hanboonkunupakarn","year":"2016","unstructured":"Hanboonkunupakarn B, White NJ. The threat of antimalarial drug resistance. Trop Dis Travel Med Vaccines. 2016;2:10.","journal-title":"Trop Dis Travel Med Vaccines."},{"key":"3269_CR12","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/jac\/dkv147","volume":"70","author":"A Huttner","year":"2015","unstructured":"Huttner A, Verhaegh EM, Harbarth S, Muller AE, Theuretzbacher U, Mouton JW. Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials. J Antimicrob Chemother. 2015;70:2456\u201364.","journal-title":"J Antimicrob Chemother"},{"key":"3269_CR13","doi-asserted-by":"crossref","unstructured":"Burri C, Chappuis F, Brun R. Human African trypanosomiasis. Manson\u2019s Tropical Infectious Diseases (23rd Edn). 2014;606\u201321.","DOI":"10.1016\/B978-0-7020-5101-2.00046-7"},{"key":"3269_CR14","doi-asserted-by":"publisher","first-page":"10488","DOI":"10.1039\/C4RA09354B","volume":"5","author":"CB Jalkute","year":"2015","unstructured":"Jalkute CB, Barage H, Sonawane KD. Insight into molecular interactions of A\u03b2 peptide and gelatinase from Enterococcus faecalis: a molecular modeling approach. RSC Adv. 2015;5:10488\u201396.","journal-title":"RSC Adv."},{"key":"3269_CR15","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1186\/1471-2105-6-S4-S10","volume":"6","author":"P D\u2019Ursi","year":"2005","unstructured":"D\u2019Ursi P, Salvi E, Fossa P, Milanesi L, Rovida E. Modelling the interaction of steroid receptors with endocrine disrupting chemicals. BMC Bioinform. 2005;6:S10\u20137.","journal-title":"BMC Bioinform."},{"key":"3269_CR16","doi-asserted-by":"publisher","first-page":"e21237","DOI":"10.1371\/journal.pone.0021237","volume":"6","author":"J Penna-Coutinho","year":"2011","unstructured":"Penna-Coutinho J, Cortopassi WA, Oliveira AA, Fran\u00e7a TCC, Krettli AU. Antimalarial activity of potential inhibitors of Plasmodium falciparum lactate dehydrogenase enzyme selected by docking studies. PLoS ONE. 2011;6:e21237.","journal-title":"PLoS ONE"},{"key":"3269_CR17","unstructured":"HyperChem(TM) Professional 8.0, Hypercube, Inc., 1115 NW 4th Street, Gainesville, Florida 32601, USA."},{"key":"3269_CR18","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1021\/ci300604z","volume":"53","author":"DR Koes","year":"2013","unstructured":"Koes DR, Baumgartner MP, Camacho CJ. Lessons learned in empirical scoring with smina from the CSAR 2011 benchmarking exercise. J Chem Inf Model. 2013;53:1893\u2013904.","journal-title":"J Chem Inf Model"},{"key":"3269_CR19","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski RA, Swindells MB. LigPlot\u2009+\u2009: multiple ligand\u2013protein interaction diagrams for drug discovery. Chem Inf Model. 2011;51:2778\u201386.","journal-title":"Chem Inf Model."},{"key":"3269_CR20","first-page":"425","volume":"50","author":"J Pant","year":"2012","unstructured":"Pant J, Deshpande SB. Acute toxicity of bisphenol A in rats. Indian J Exp Biol. 2012;50:425\u20139.","journal-title":"Indian J Exp Biol"},{"key":"3269_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/00034983.1975.11686997","volume":"69","author":"W Peters","year":"1975","unstructured":"Peters W. The four-day suppressive in vivo antimalarial test. Ann Trop Med Parasitol. 1975;69:155\u201371.","journal-title":"Ann Trop Med Parasitol"},{"key":"3269_CR22","volume-title":"Guide for the care and use of laboratory animals","author":"National Research Council","year":"1996","unstructured":"National Research Council. Guide for the care and use of laboratory animals. Washington DC: National Academies Press; 1996."},{"key":"3269_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/00034983.1970.11686683","volume":"64","author":"J Ryley","year":"1970","unstructured":"Ryley J, Peters W. The antimalarial activity of some quinolone esters. Ann Trop Med Parasitol. 1970;64:209\u201322.","journal-title":"Ann Trop Med Parasitol"},{"key":"3269_CR24","volume-title":"Carleton\u2019s histological technique","author":"HM Carleton","year":"1980","unstructured":"Carleton HM, Drury RAB, Wallington EA. Carleton\u2019s histological technique. Oxford: Oxford University Press; 1980."},{"key":"3269_CR25","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1097\/00007890-199112000-00008","volume":"52","author":"S Suzuki","year":"1991","unstructured":"Suzuki S, Nakamura S, Koizumi T, Sakaguchi S, Baba S, Muro H, et al. The beneficial effect of a prostaglandin I2 analog on ischemic rat liver. Transplant. 1991;52:979\u201383.","journal-title":"Transplant."},{"issue":"17","key":"3269_CR26","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.bmc.2009.01.021","volume":"15","author":"M Yang","year":"2009","unstructured":"Yang M, Ge JF, Arai C, Itoh I, Fu Q, Ihara M. Pharmacodynamics and pharmacokinetics studies of phenoxazinium derivatives for antimalarial agent. Bioorg Med Chem. 2009;15(17):1481\u20135.","journal-title":"Bioorg Med Chem"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-03269-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-020-03269-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-03269-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T20:05:15Z","timestamp":1624910715000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-020-03269-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,29]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3269"],"URL":"https:\/\/doi.org\/10.1186\/s12936-020-03269-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.20201\/v1","asserted-by":"object"}]},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,29]]},"assertion":[{"value":"3 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All applicable and acceptable guidelines for the care and use of animals were followed in the study. The research committee and institutional Ethics Committee of the Pasteur Institute of Iran approved this project (No. IR.PII.REC.1396.40).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The publication of this manuscript was approved by Pasteur Institute of Iran.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"231"}}